(Q37287394)

English

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

scientific article published on 07 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial (English)

1 reference

Europe PubMed Central

19 August 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

N Tubiana-Mathieu

1

1 reference

Europe PubMed Central

19 August 2017

P Bougnoux

2

1 reference

Europe PubMed Central

19 August 2017

D Becquart

3

1 reference

Europe PubMed Central

19 August 2017

A Chan

4

1 reference

Europe PubMed Central

19 August 2017

P-F Conte

5

1 reference

Europe PubMed Central

19 August 2017

F Majois

6

1 reference

Europe PubMed Central

19 August 2017

M Espie

7

1 reference

Europe PubMed Central

19 August 2017

M Morand

8

1 reference

Europe PubMed Central

19 August 2017

N Vaissiere

9

1 reference

Europe PubMed Central

19 August 2017

G Villanova

10

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

7 July 2009

1 reference

Europe PubMed Central

19 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

19 August 2017

101

1 reference

Europe PubMed Central

19 August 2017

2

1 reference

Europe PubMed Central

19 August 2017

232-237

1 reference

Europe PubMed Central

19 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605156

0 references

Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Effective oral chemotherapy for breast cancer: pillars of strength.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Extending survival with chemotherapy in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

6 September 2017

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

28 September 2017

A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720198

3 September 2018

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605156

21 January 2018

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19584872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19584872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19584872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605156

1 reference

Europe PubMed Central

19 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37287394&oldid=2149158571"